Pre- and Post-Balloon-Occluded Retrograde Transvenous Obliteration Clinical Evaluation, Management, and Imaging: Indications, Management Protocols, and Follow-up

Techniques in Vascular and Interventional Radiology

Volumn 15, Issue 3, 2012, Pages 165-202

  Saad, Wael E A ^a   Al Osaimi, Abdullah M S ^a   Caldwell, Stephen H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

BRTO; Gastric; Liver cirrhosis; Portal hypertension; TIPS; Transvenous obliteration; Varices

Indexed keywords

ARTICLE; BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; BALLOON OCCLUSION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; ENDOSCOPY; FLUID RESUSCITATION; FOLLOW UP; GASTRIC VARICEAL BLEEDING; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; RADIOLOGIST; STOMACH VARICES; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNITED STATES;

ANGIOGRAPHY, DIGITAL SUBTRACTION; BALLOON OCCLUSION; COOPERATIVE BEHAVIOR; DECOMPRESSION, SURGICAL; DIAGNOSTIC IMAGING; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; HYPERTENSION, PORTAL; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE TEAM; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PREDICTIVE VALUE OF TESTS; RADIOGRAPHY, INTERVENTIONAL; RECURRENCE; TREATMENT OUTCOME;

EID: 84866871340     PISSN: 10892516     EISSN: 15579808     Source Type: Journal    
DOI: 10.1053/j.tvir.2012.07.003     Document Type: Article

References (72)

1. Al-Osaimi A.M.S., Caldwell S.H. Medical and endoscopic management of gastric varices. Semin Interv Radiol 2011, 28:273-282.
2. Caldwell S.H., Hespenheide E.E., Greenwald B.D., et al. Enbucrilate for gastric varices: Extended experience in 92 patients. Aliment Pharmacol Ther 2007, 26:49-59.
3. Agarwal A.K., Raj Kumar K., Agarwal S., et al. Significance of splenic vein thrombosis in chronic pancreatitis. Am J Surg 2008, 196:149-154.
4. Heider T.R., Azeem S., Galanko J.A., et al. The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg 2004, 239:876-880.
5. Trudeau W., Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986, 32:264-268.
6. Al-Osaimi A.M.S., Sabri S.S., Caldwell S.H. Balloon-occluded retrograde transvenous obliteration (BRTO): Preprocedural evaluation and imaging. Semin Interv Radiol 2011, 28:288-295.
7. Saad W.E.A., Darcy M.D. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin Interv Radiol 2011, 28:339-349.
8. Saad W.E.A., Sabri S.S. Balloon-occluded retrograde transvenous obliteration (BRTO): Technical results and outcomes. Semin Interv Radiol 2011, 28:333-338.
9. Saad W.E.A. The history and evolution of balloon-occluded retrograde transvenous obliteration (BRTO): From the United States to Japan and back. Semin Interv Radiol 2011, 28:283-287.
10. Kanagawa H., Mima S., Kouyama H., et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996, 11:51-58.
11. Kiyosue H., Mori H., Matsumoto S., et al. Transcatheter Oliteration of gastric varices: Part-1: Anatomic classification. Radiographics 2003, 23:911-920.
12. Kiyosue H., Mori H., Matsumoto S., et al. Transcatheter Oliteration of gastric varices: Part-2: Strategy and techniques based on hemodynamic features. Radiographics 2003, 23:921-937.
13. Yamagami T., Kato T., Hirota T., et al. Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration Australian. Radiology 2007, 51:334-338.
14. Kitamoto M., Imamura M., Kamada K., et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol 2002, 178:1167-1174.
15. Ninoi T., Nakamura K., Kaminou T., et al. TIPS versus transcatheter sclerotherapy for gatsric varices. AJR Am J Roentgenol 2004, 183:369-376.
16. Ninoi T., Nishida N., Kaminou T., et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: Long-term follow-up in 78 patients. AJR Am J Roentgenol 2005, 184:1340-1346.
17. Akahoshi T., Hashizume M., Tomikawa M., et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: A 10-year experience. J Gastroenterol Hepatol 2008, 23:1702-1709.
18. Fukuda T., Hirota S., Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001, 12:327-336.
19. Sonomura T., Sato M., Kishi K., et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: A feasibility study. Cardiovasc Interv Radiol 1998, 21:27-30.
20. Kiyosue H., Matsumoto S., Onishi R., et al. Balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices: Therapeutic results and problems. Nippon Igaku Hoshasen Gakkai Zasshi 1999, 59:12-19.
21. Koito K., Namieno T., Nagakawa T., et al. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol 1996, 167:1317-1320.
22. Chikamori F., Kuniyoshi N., Kawashima T., et al. Gastric varices with gastrorenal shunt: Combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roentgenol 2008, 191:555-559.
23. Kumamoto M., Toyonaga A., Inoue H., et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol 2010, 25:1129-1135.
24. Chikamori F., Kuniyoshi N., Shibuya S., et al. Transjugular retrograde obliteration for chronic portosystemic encephalopathy. Abdom Imaging 2000, 25:567-571.
25. Chikamori F., Kuniyoshi N., Shibuya S., et al. Combination treatment of transjugular retrograde obliteration and endoscopic embolization for portosystemic encephalopathy with esophageal varices. Hepatogastroenterology 2004, 51:1379-1381.
26. Chikamori F., Kuniyoshi N., Shibuya S., et al. Eight years of experience with transjugular retrograde obliteration for gastric varices with Gastrorenal shunts. Surgery 2001, 129:414-420.
27. Miyamoto Y., Oho K., Kumamoto M., et al. Balloon-occluded retrograde transvenous obliteration improves Liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol 2003, 18:934-942.
28. Hirota S., Matsumoto S., Tomita M., et al. Retrograde transvenous obliteration of gastric varices. Radiology 1999, 211:349-356.
29. Sugimori K., Morimoto M., Shirato K., et al. Retrograde transvenous obliteration of gastric varices associated with large collateral veins or a large gastrorenal shunt. JVIR J vasc Intrev Radiol 2005, 16:113-118.
30. Fukuda T., Hirota S., Matsumoto S., et al. Application of balloon-occluded retrograde transvenous obliteration to gastric varices complicating refractory ascites. Cardiovasc Intervent Radiol 2004, 27:64-67.
31. Shimoda R., Horiuchi K., Hagiwara S., et al. Short-term complications of balloon-occluded retrograde transvenous obliteration of gastric varices in patients with portal hypertension: Effects of obliteration of major portosystemic shunts. Abdom Imaging 2005, 30:306-313.
32. Takuma Y., Nouso K., Makino Y., et al. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol 2005, 3:1245-1252.
33. Arai H., Abe T., Takagi H., et al. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol 2006, 12:3866-3873.
34. Arai H., Abe T., Shimoda R., et al. Emergency balloon-occluded retrograde transvenous obliteration for gastric fundal varices. J Gastroenterol 2005, 40:964-971.
35. Park S.J., Chung J.W., Kim H.C., et al. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. JVIR J Vasc Interv Radiol 2010, 21:503-507.
36. Hong C.H., Kim H.J., Park J.H., et al. Treatment of patients with gastric variceal hemorrhage: Endoscopic N-Butyl-2Cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. Hepatology 2009, 24:372-378.
37. Park K.S., Kim Y.H., Choi J.S., et al. Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding. Korean J Gastroenterol 2006, 47:370-378.
38. Kim E.S., Park S.Y., Kwon K.T., et al. The clinical usefulness of balloon-occluded retrograde transvenous obliteration in gastric variceal bleeding. Teehan Kan Hakhoe Chi 2003, 9:315-323.
39. Cho S.K., Shin S.W., Lee I.H., et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: Outcomes and complications in 49 patients. AJR Am J Roentgenol 2007, 189:W365-W372.
40. Choi Y.H., Yoon C.J., Park J.H., et al. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: Its feasibility compared with transjugular intrahepatic portosystemic shunt (TIPS). Korean J Radiol 2003, 4:109-116.
41. Kim T., Shijo H., Kokawa H., et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997, 25:307-312.
42. Kravetz D., Bosch J., Arderiu M., et al. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: Influence of the extent of portal-systemic shunting. Hepatology 1989, 9:808-814.
43. Castañeda B., Morales J., Lionetti R., et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology 2001, 33:821-825.
44. Villanueva C., Ortiz J., Miñana J., et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology 2001, 121:110-117.
45. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005, 43:167-176.
46. Gabriel D.A., Li X., Monroe D.M., et al. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost 2004, 2:1816-1822.
47. Economopoulos K.P., Choussein S., Sergentanis T.N., et al. Early use of TIPS for cirrhosis and variceal bleeding. N Engl J Med 2010, 362:2370-2379.
48. Garcia-Tsao G., Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010, 362:823-832.
49. Sarin S.K. Long-term follow-up of gastric variceal sclerotherapy: An eleven-year experience. Gastrointest Endosc 1997, 46:8-14.
50. Jutabha R., Jensen D.M., Kovacs T.O.G., et al. Initial results of combination banding and sclerotherapy compared to sclerotherapy alone for bleeding gastric varices. Gastrointest Endosc 1998, 47:AB86.
51. Tan P.C., Hou M.C., Lin H.C., et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-Butyl-2-Cyanoacrylate injection vs. band ligation. Hepatology 2006, 43:690-697.
52. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of butyl cyanoacrylate injection vs. band ligation in the management of bleeding gastric varices. Hepatology 2001, 33:1060-1064.
53. Yang W.L., Tripathi D., Therapondos G., et al. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol 2002, 97:1381-1385.
54. Araki T., Hori M., Motosugi U., et al. Can balloon-occluded retrograde transvenous obliteration Be performed for gastric varices without gastrorenal shunts?. JVIR J Vasc Interv Radiol 2010, 21:663-670.
55. Ota K., Okazaki M., Higashihara H., et al. Combination of transileocolic vein obliteration and balloon-occluded retrograde transvenous obliteration is effective for ruptured duodenal varices. J Gastroenterol 1999, 34:694-699.
56. Ono S., Irie T., Kuramochi M., et al. Successful treatment of mesenteric varices with balloon-occluded retrograde transvenous obliteration via an abdominal wall vein. JVIR J Vasc Interv Radiol 2007, 18:1033-1035.
57. Ibukuro K., Sugihara T., Tanaka R., et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. JVIR J Vasc Interv Radiol 2007, 18:121-125.
58. Kimura T., Haruta I., Isobe Y., et al. A novel therapeutic approach for rectal varices: A case report of rectal varices treated with double balloon-occluded embolotherapy. Am J Gastroenterol 1997, 92:883-886.
59. Akazawa Y., Murata I., Yamao T., et al. Successful management of bleeding duodenal varices by endoscopic variceal ligation and balloon-occluded retrograde transvenous obliteration. Gastrointest Endosc 2003, 58:794-797.
60. Tominaga K., Montani A., Kuga T., et al. Combined balloon-occluded embolization for treatment of concurrent duodenal, gastric, and esophageal varices: A case report. Gastrointest Endosc 2001, 53:665-668.
61. Onozato Y., Kakizaki S., Iizuka H., et al. Ectopic varices rupture in gastroduodenal anastomosis successfully treated with N-butyl-2-Cyanoacrylate injection. Acta Med Okayama 2007, 61:361-365.
62. Zamora C.A., Sugimoto K., Tsurusaki M., et al. Endovascular obliteration of bleeding duodenal varices in patients with Liver cirrhosis. Eur Radiol 2006, 16:73-79.
63. Haruta I., Isobe Y., Ueno E., et al. Balloon-occluded retrograde transvenous obliteration (BRTO): A promising nonsurgical therapy for ectopic varices: A case report of successful treatment of duodenal varices by BRTO. Am J Gatsroenterol 1996, 91:2594-2597.
64. Ohta M., Yasumori K., Saku M., et al. Successful treatment of bleeding duodenal varices by balloon-occluded retrograde transvenous obliteration: A transjugular venous approach. Surgery 1999, 126:581-583.
65. Sonomura T., Horihata K., Yamahara K., et al. Ruptured duodenal varices successfully treated with balloon-occluded retrograde transvenous obliteration: Usefulness of microcatheters. AJR Am J Roentgenol 2003, 181:725-727.
66. Tsurusaki M., Sugimoto K., Matsumoto S., et al. Bleeding duodenal varices successfully treated with balloon-occluded retrograde transvenous obliteration (B-RTO) assisted by CT during arterial portography. Cardiovasc Intervent Radiol 2006, 29:1148-1151.
67. Hiraga N., Aikata H., Takaki S., et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol 2007, 42:663-672.
68. Sauer B.G., Sabri S.S., Shami V.M., et al. Post-balloon-occluded retrograde transvenous obliteration (BRTO) imaging and management. Semin Interv Radiol 2011, 28:288-295.
69. Iwase H., Suga S., Morise K., et al. Color Doppler endoscopic ultrasonography for the evaluation of gastric varices and endoscopic obliteration with cyanoacrylate glue. Gastrointest Endosc 1995, 41:150-154.
70. Konishi Y., Nakamura T., Kida H., et al. Catheter US probe EUS evaluation of gastric cardia and perigastric vascular structures to predict esophageal variceal recurrence. Gastrointest Endosc 2002, 55:197-203.
71. Lo G.H., Lai K.H., Cheng J.S., et al. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy. Gastrointest Endosc 1999, 49:428-436.
72. Wong R.C., Farooq F.T., Chak A. Endoscopic Doppler US probe for the diagnosis of gastric varices (with videos). Gastrointest Endosc 2007, 65:491-496.